Nu Skin Enterprises Inc logo

Nu Skin Enterprises Inc(NUS)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
1-STAR RATING
SELL
SELL for 2 days
PROFIT SINCE LAST BUY
-13.05% ▼
LAST CLOSE
$4.1
11/06/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for NUS

11/06/2026: NUS (1-star) is a SELL. SELL for 2 days. Simulated Profits (-13.05%). Updated daily EoD!

Nu Skin Enterprises is a global personal care and wellness company that distributes products through a network of independent sales leaders. Its main strength lies in its science-based ageLOC brand and a long-standing history of consistent dividend payments. The primary investment story centers on the company's ongoing effort to modernize its direct-selling model via digital platforms to attract new consumers. However, the company faces significant risks from intense competition, regulatory scrutiny, and the inherent challenges of the direct-selling recruitment structure. The stock may best suit dividend-oriented investors seeking steady income, provided they monitor the company's success in digital sales transformation and international market stability.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorMixed fitGrowth is currently constrained by industry headwinds, making future appreciation dependent on successful digital transformation.
Momentum investorWeak fitThe stock lacks the consistent upward momentum typically sought by this style unless a clear, sustained upturn in revenue emerges.
Value investorStrong fitThe stock may offer an attractive entry point for value investors if it trades at lower valuation multiples relative to historical averages.
Dividend investorStrong fitThe company has maintained a consistent history of dividend payments, providing reliable income for income-oriented investors.
Low-risk investorMixed fitThe business model faces regulatory and operational risks common to the direct-selling sector, introducing moderate volatility.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityMedium / highThe stock is subject to fluctuations driven by regional sentiment and market conditions affecting direct-selling companies.
Valuation riskMediumInvestors must weigh the current share price against the company's ability to revitalize long-term revenue growth.
Competition risk (Direct-selling and Retail)HighIntense pressure from social media influencers and digital-native skincare brands threatens traditional sales channels.
Business qualityMediumThe business has historically maintained stable operating margins, though it faces structural challenges in a changing retail environment.
Dividend incomeLowThe dividend is relatively stable, though long-term sustainability depends on maintaining sufficient free cash flow.
Execution riskMedium / highSuccess depends on effectively pivoting the sales force to digital platforms without alienating the existing, high-performing distributor base.

Price Behavior

Steep Decline
PRICE PATH

Steep Decline

The stock price has dropped sharply with strong downward pressure.

Choppy
PRICE STABILITY

Choppy

The stock has experienced frequent reversals and pronounced short-term price swings.

Analysis of Past Performance

Type Stock
Historic Profit -46.13%
Avg. Invested days 24
Today’s Advisory SELL
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/06/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
NUS receives a 3-star rating, supported by solid company fundamentals. The rating is constrained by soft unit economics, and weak price momentum.

Company Fundamentals

★★★★★
NUS has solid overall fundamentals (4 stars), with moderate financial health, moderate growth momentum, and solid ownership. In FY2025 versus FY2024, strong earnings growth (+209.3%) and solid profitability (net margin 10.8%) are partially offset by soft cash generation (FCF margin 3.1%), negative revenue growth (-14.3%), modest insider ownership of 3.40%.

Financial Health Rating

★★★★★
NUS's financial health is supported by solid cash strength, including free-cash-flow generation (3.1% of revenue). Profitability is moderate (3 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
Earnings growth is NUS's strongest growth driver at +209.3% FY2025 versus FY2024 (strong, 5 stars). By comparison, while revenue growth (-14.3%, negative) and free-cash-flow growth (-34.4%, negative) hold the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 75.2% and approximately 97.1% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 3.40% provides only moderate management-shareholder alignment.

Top 5 Institutional Investors

BlackRock Inc 8.87%
American Century Companies Inc 4.73%
Vanguard Capital Management, LLC 4.21%
Acadian Asset Management LLC 4.01%
Prescott Group Capital Management LLC 3.69%

Unit Economics (Per $1K Revenue)

★★★★★
NUS generates approximately $694 of gross profit, $61 of operating income, and $31 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Moderate margins explain the 2-star rating, with weak cash conversion and soft capital efficiency.

Economic Dimensions

★★★★★
Effective Tax Rate: 18.35%

Quantitative Style Profile

★★★★★
NUS has a liquid profile. Weak momentum is the primary drawback.

Style Classification

Quality Focused

Value-OrientedSmall / Mid Cap RiskShort Squeeze RiskHighly Liquid / Institution-Friendly

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 199.58M USD
Price to earnings Ratio -
1Y Target Price 12.48
Price to earnings Ratio -
1Y Target Price 12.48
Volume (30-day avg) 481.6K shares
Beta 0.93
52 Weeks Range 4.09 - 11.33
Updated Date 11/08/2026
52 Weeks Range 4.09 - 11.33
Updated Date 11/08/2026
Dividends yield (FY) 5.30%
Basic EPS (TTM) -4.86

How Company Makes Money

Business areaWhat it includesRetail investor read
Beauty and Wellness SalesRevenue from the sale of ageLOC skincare devices, supplements, and cosmetic products.The company makes money primarily by selling consumable beauty and health products through its global network.
Geographic MarketsOperations in Mainland China, Americas, EMEA, and other parts of Asia.Global diversification is key, as different regions face unique regulatory and economic conditions that impact revenue.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2026-11-05
When After Market
Estimate 0.21
Actual 0.1

Profitability

Profit Margin -17.72%
Operating Margin (TTM) 1.64%

Management Effectiveness

Return on Assets (TTM) 2.67%
Return on Equity (TTM) -34.77%

Valuation

Trailing PE -
Forward PE 3.53
Enterprise Value 285.35M
Price to Sales(TTM) 0.15
Enterprise Value 285.35M
Price to Sales(TTM) 0.15
Enterprise Value to Revenue 0.22
Enterprise Value to EBITDA 7.6
Shares Outstanding 48.68M
Shares Floating 47.27M
Shares Outstanding 48.68M
Shares Floating 47.27M
Percent Insiders 3.4
Percent Institutions 75.19

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.